Advanced Enzyme Technologies has informed that the Board of Directors in its meeting held on November 02, 2019, has transacted approval of the Unaudited Financial Results of the Company (Standalone & Consolidated) for the quarter and half year ended September 30, 2019. Further, the Company enclosed Unaudited Financial Results (Standalone & Consolidated) for the quarter ended September 30, 2019 along with the Limited Review report issued by B S R & Co. LLP, Statutory Auditors of the Company as Annexure - I; and Earnings Presentation for the quarter and half year ended September 30, 2019.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1887.95 |
| Dr. Reddys Labs. | 1348.70 |
| Cipla | 1431.65 |
| Zydus Lifesciences | 1149.00 |
| Lupin | 2457.45 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: